… In this review, we discuss the immunobiology of PD-L1, with a particular focus on its …
PD-1/PD-L1.23 HIV-specific CD4/CD8 cells coexpress PD-1, and a similar role for PD-1/PD-L1 has …

… -PD-1 therapies for three tumor histotypes: MM, NSCLC and RCC. All of them are the focus
of the present systematic review … receiving anti-PD-1/PD-L1 therapy has been reviewed and …

… Findings In this systematic review and meta-analysis involving … than PD-L1 IHC, tumor
mutational burden, or gene expression profiling in predicting clinical response to anti–PD-1/PD-L1 …

… Based on these perspectives, PD-1/PD-L1 axis is responsible … review is aimed to summarize
the role of PD-1 and PD-L1 in … of the present review was to elucidate the role of PD-1/PD-L1 …

… review focuses on PD-L1 expression and its association with clinical outcomes in GC.
Furthermore, this research attempts to show that the potential of PD-L1 … inhibition of PD-L1/PD-1 …

… Despite the marked success of applications of PD-1/PD-L1 checkpoint … In this review, we
discuss the current progress and … PD-L1 expression is a logical biomarker for the prediction of …

… Therefore, furthering our understanding of the regulatory mechanisms of PD-L1 can bring …
PD-L1/PD-1 blockade or other ICBs. In this review, we provide current knowledge of PD-L1 …

… PD-L1 IHC assays, we systematically … PD-L1 IHC tests in lung cancer, most using
immunohistochemistry testing. There was significant heterogeneity among the available tests for …

… review, we summarized the synergistic antitumor efficacies and mechanisms of α-PD-1/PD-L1 …
Moreover, we focused on the advances of α-PD-1/PD-L1-based immunomodulatory …

… (PD-1/PD-L1) is a negative modulatory signaling pathway for activation of T cell. It is
acknowledged that PD-1/PD-L1 … immune therapy strategies, PD-1/PD-L1 inhibitor is a …